| meta-analysis | Q815382 |
| systematic review | Q1504425 |
| scholarly article | Q13442814 |
| P50 | author | Brian Greenwood | Q4963885 |
| Cally Roper | Q28913764 | ||
| Jorge Cano | Q57904698 | ||
| Daniel Chandramohan | Q60031943 | ||
| P2093 | author name string | Cono Ariti | |
| R Matthew Chico | |||
| Timothy J Collier | |||
| P2860 | cites work | Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis | Q26849714 |
| Rapid dissemination of Plasmodium falciparum drug resistance despite strictly controlled antimalarial use | Q28469104 | ||
| High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581 | Q28474860 | ||
| Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review | Q33288230 | ||
| Sulfadoxine-pyrimethamine-based combinations for malaria: a randomised blinded trial to compare efficacy, safety and selection of resistance in Malawi | Q33319559 | ||
| A randomized placebo-controlled trial of intermittent preventive treatment in pregnant women in the context of insecticide treated nets delivered through the antenatal clinic | Q33327356 | ||
| Molecular epidemiology of drug-resistant malaria in western Kenya highlands | Q33356795 | ||
| Molecular correlates of high-level antifolate resistance in Rwandan children with Plasmodium falciparum malaria | Q33559071 | ||
| Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria | Q33889085 | ||
| Mutations associated with sulfadoxine-pyrimethamine and chlorproguanil resistance in Plasmodium falciparum isolates from Blantyre, Malawi | Q33935361 | ||
| Sulfadoxine-pyrimethamine resistance and intermittent preventive treatment during pregnancy: a retrospective analysis of birth weight data in the Democratic Republic of Congo (DRC). | Q34115647 | ||
| Quantitative methods in the review of epidemiologic literature | Q34187297 | ||
| Efficacy of malaria prevention during pregnancy in an area of low and unstable transmission: an individually-randomised placebo-controlled trial using intermittent preventive treatment and insecticide-treated nets in the Kabale Highlands, southweste | Q34383001 | ||
| Increased prevalence of the pfdhfr/phdhps quintuple mutant and rapid emergence of pfdhps resistance mutations at codons 581 and 613 in Kisumu, Kenya | Q34405184 | ||
| Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance | Q35452357 | ||
| The A581G Mutation in the Gene Encoding Plasmodium falciparum Dihydropteroate Synthetase Reduces the Effectiveness of Sulfadoxine-Pyrimethamine Preventive Therapy in Malawian Pregnant Women | Q35965229 | ||
| Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya | Q36077922 | ||
| Plasmodium falciparum sulfadoxine resistance is geographically and genetically clustered within the DR Congo | Q36572916 | ||
| Differential effect of regional drug pressure on dihydrofolate reductase and dihydropteroate synthetase mutations in southern Mozambique. | Q37108868 | ||
| Field-based evidence of fast and global increase of Plasmodium falciparum drug-resistance by DNA-microarrays and PCR/RFLP in Niger | Q37126331 | ||
| Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment | Q37211417 | ||
| Impact of trimethoprim-sulfamethoxazole prophylaxis on falciparum malaria infection and disease | Q37339874 | ||
| dhfr and dhps genotype and sulfadoxine-pyrimethamine treatment failure in children with falciparum malaria in the Democratic Republic of Congo | Q37396146 | ||
| Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2013 meeting | Q37496851 | ||
| On the pathway to better birth outcomes? A systematic review of azithromycin and curable sexually transmitted infections | Q37530197 | ||
| Prevalence of malaria and sexually transmitted and reproductive tract infections in pregnancy in sub-Saharan Africa: a systematic review | Q37848714 | ||
| Mapping 'partially resistant', 'fully resistant', and 'super resistant' malaria | Q38136762 | ||
| Emergence of a dhfr mutation conferring high-level drug resistance in Plasmodium falciparum populations from southwest Uganda | Q38876271 | ||
| Individual efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine in primi- and secundigravidae in rural Burkina Faso: impact on parasitaemia, anaemia and birth weight | Q39023258 | ||
| Low-dose treatment with sulfadoxine-pyrimethamine combinations selects for drug-resistant Plasmodium falciparum strains | Q39152224 | ||
| Plasmodium falciparum dhfr but not dhps mutations associated with sulphadoxine-pyrimethamine treatment failure and gametocyte carriage in northern Ghana | Q39257141 | ||
| Malaria and anemia in antenatal women in Blantyre, Malawi: a twelve-month survey. | Q39549953 | ||
| Effect of topography on the risk of malaria infection in the Usambara Mountains, Tanzania | Q39684756 | ||
| Malaria in pregnancy before and after the implementation of a national IPTp program in Gabon. | Q39812394 | ||
| Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins | Q41927581 | ||
| Antifolate drug resistance and point mutations in Plasmodium falciparum in Kenya | Q41928091 | ||
| Malaria prevention during pregnancy: assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupela District, Burkina Faso. | Q41944762 | ||
| Can pretreatment screening for dhps and dhfr point mutations in Plasmodium falciparum infections be used to predict sulfadoxine-pyrimethamine treatment failure? | Q43699456 | ||
| Effectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection | Q44033849 | ||
| DHFR and DHPS genotypes of Plasmodium falciparum isolates from Gabon correlate with in vitro activity of pyrimethamine and cycloguanil, but not with sulfadoxine-pyrimethamine treatment efficacy | Q44477167 | ||
| Implementation of intermittent preventive treatment with sulphadoxine-pyrimethamine for control of malaria in pregnancy in Kisumu, western Kenya | Q44874460 | ||
| A randomized, placebo-controlled trial of intermittent preventive treatment with sulphadoxine-pyrimethamine in Gambian multigravidae. | Q48032256 | ||
| A random-effects regression model for meta-analysis | Q72228939 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | meta-analysis | Q815382 |
| systematic review | Q1504425 | ||
| pregnancy-associated malaria | Q7239883 | ||
| malaria transmission | Q56928847 | ||
| P304 | page(s) | 1621-33 | |
| P577 | publication date | 2015-12-01 | |
| P1433 | published in | Tropical Medicine and International Health | Q15765747 |
| P1476 | title | Influence of malaria transmission intensity and the 581G mutation on the efficacy of intermittent preventive treatment in pregnancy: systematic review and meta-analysis | |
| P478 | volume | 20 |
| Q37533439 | Burden of Placental Malaria among Pregnant Women Who Use or Do Not Use Intermittent Preventive Treatment at Mulago Hospital, Kampala |
| Q89980597 | Coverage and effectiveness of intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) on adverse pregnancy outcomes in the Mount Cameroon area, South West Cameroon |
| Q92230251 | Devising a strategy for prevention of malaria in pregnant women in the Asia Pacific |
| Q92684763 | Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis |
| Q92580319 | Effectiveness of intermittent screening and treatment for the control of malaria in pregnancy: a cluster randomised trial in India |
| Q56376468 | Efficacy of artemisinin-based combination therapies and prevalence of molecular markers associated with artemisinin, piperaquine and sulfadoxine-pyrimethamine resistance in Sierra Leone |
| Q39413965 | Evaluation of Malaria Screening during Pregnancy with Rapid Diagnostic Tests Performed by Community Health Workers in Burkina Faso. |
| Q97546624 | High multiple mutations of Plasmodium falciparum-resistant genotypes to sulphadoxine-pyrimethamine in Lagos, Nigeria |
| Q33617916 | Increase in the prevalence of mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates collected from early to late pregnancy in Nanoro, Burkina Faso |
| Q36478633 | Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an op |
| Q36094714 | Lack of effect of intermittent preventive treatment for malaria in pregnancy and intense drug resistance in western Uganda |
| Q38636047 | Mapping sulphadoxine-pyrimethamine-resistant Plasmodium falciparum malaria in infected humans and in parasite populations in Africa |
| Q92091395 | Markers of sulfadoxine-pyrimethamine resistance in Eastern Democratic Republic of Congo; implications for malaria chemoprevention |
| Q28125938 | Molecular monitoring of Plasmodium falciparum super-resistance to sulfadoxine-pyrimethamine in Tanzania |
| Q92610098 | Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial |
| Q96613080 | Overall, anti-malarial, and non-malarial effect of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine on birthweight: a mediation analysis |
| Q48514593 | Prevention of malaria in pregnancy |
| Q38944061 | Prevention of malaria in pregnancy: a fork in the road? |
| Q28468589 | Profile of molecular mutations in pfdhfr, pfdhps, pfmdr1, and pfcrt genes of Plasmodium falciparum related to resistance to different anti-malarial drugs in the Bata District (Equatorial Guinea) |
| Q33910163 | Resisting and tolerating P. falciparum in pregnancy under different malaria transmission intensities |
| Q28554025 | Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized [...] |
| Q33589254 | Sulfadoxine-Pyrimethamine Exhibits Dose-Response Protection Against Adverse Birth Outcomes Related to Malaria and Sexually Transmitted and Reproductive Tract Infections |
| Q28079877 | The influence of pregnancy on the pharmacokinetic properties of artemisinin combination therapy (ACT): a systematic review |
| Q35960893 | User and Provider Acceptability of Intermittent Screening and Treatment and Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine to Prevent Malaria in Pregnancy in Western Kenya |
| Q91759547 | Widespread resistance mutations to sulfadoxine-pyrimethamine in malaria parasites imported to China from Central and Western Africa |
Search more.